blood clots.Some estimates suggest that the novel coronavirus causes blood clots in 30% of critically ill patients, which can lead to serious complications, including strokes.These findings have motivated researchers to test whether existing blood-thinning drugs typically used to prevent blood clots after a heart attack, for example, could improve outcomes for people with COVID-19.
However, precisely what causes the blood clots to form in people with the illness remains unclear.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.New research led by a team from the University of Michigan suggests that a type of autoantibody usually seen in people with the.